BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

814 related articles for article (PubMed ID: 33995342)

  • 1. Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1).
    Choreño-Parra JA; Jiménez-Álvarez LA; Cruz-Lagunas A; Rodríguez-Reyna TS; Ramírez-Martínez G; Sandoval-Vega M; Hernández-García DL; Choreño-Parra EM; Balderas-Martínez YI; Martinez-Sánchez ME; Márquez-García E; Sciutto E; Moreno-Rodríguez J; Barreto-Rodríguez JO; Vázquez-Rojas H; Centeno-Sáenz GI; Alvarado-Peña N; Salinas-Lara C; Sánchez-Garibay C; Galeana-Cadena D; Hernández G; Mendoza-Milla C; Domínguez A; Granados J; Mena-Hernández L; Pérez-Buenfil LÁ; Domínguez-Cheritt G; Cabello-Gutiérrez C; Luna-Rivero C; Salas-Hernández J; Santillán-Doherty P; Regalado J; Hernández-Martínez A; Orozco L; Ávila-Moreno F; García-Latorre EA; Hernández-Cárdenas CM; Khader SA; Zlotnik A; Zúñiga J
    Front Immunol; 2021; 12():593595. PubMed ID: 33995342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine/Chemokine Expression Is Closely Associated Disease Severity of Human Adenovirus Infections in Immunocompetent Adults and Predicts Disease Progression.
    Li J; Wei J; Xu Z; Jiang C; Li M; Chen J; Li Y; Yang M; Gu Y; Wang F; Shu Y; Yang Y; Sun L; Liu Y
    Front Immunol; 2021; 12():691879. PubMed ID: 34163488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T helper type (Th1/Th2) responses to SARS-CoV-2 and influenza A (H1N1) virus: From cytokines produced to immune responses.
    Aleebrahim-Dehkordi E; Molavi B; Mokhtari M; Deravi N; Fathi M; Fazel T; Mohebalizadeh M; Koochaki P; Shobeiri P; Hasanpour-Dehkordi A
    Transpl Immunol; 2022 Feb; 70():101495. PubMed ID: 34774738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome.
    Choreño-Parra JA; Jiménez-Álvarez LA; Ramírez-Martínez G; Sandoval-Vega M; Salinas-Lara C; Sánchez-Garibay C; Luna-Rivero C; Hernández-Montiel EM; Fernández-López LA; Cabrera-Cornejo MF; Choreño-Parra EM; Cruz-Lagunas A; Domínguez A; Márquez-García E; Cabello-Gutiérrez C; Bolaños-Morales FV; Mena-Hernández L; Delgado-Zaldivar D; Rebolledo-García D; Guadarrama-Ortiz P; Regino-Zamarripa NE; Mendoza-Milla C; García-Latorre EA; Rodiguez-Reyna TS; Cervántes-Rosete D; Hernández-Cárdenas CM; Khader SA; Zlotnik A; Zúñiga J
    Front Immunol; 2021; 12():633297. PubMed ID: 33717172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Surfactant Protein D Distinguishes Severe Pandemic Influenza A(H1N1) from Coronavirus Disease 2019.
    Choreño-Parra JA; Jiménez-Álvarez LA; Ramírez-Martínez G; Cruz-Lagunas A; Thapa M; Fernández-López LA; Carnalla-Cortés M; Choreño-Parra EM; Mena-Hernández L; Sandoval-Vega M; Hernández-Montiel EM; Hernández-García DL; Ramírez-Noyola JA; Reyes-López CE; Domínguez-Faure A; Zamudio-López GY; Márquez-García E; Moncada-Morales A; Mendoza-Milla C; Cervántes-Rosete D; Muñoz-Torrico M; Luna-Rivero C; García-Latorre EA; Guadarrama-Ortíz P; Ávila-Moreno F; Domínguez-Cherit G; Rodríguez-Reyna TS; Mudd PA; Hernández-Cárdenas CM; Khader SA; Zúñiga J
    J Infect Dis; 2021 Jul; 224(1):21-30. PubMed ID: 33668070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19.
    Thwaites RS; Sanchez Sevilla Uruchurtu A; Siggins MK; Liew F; Russell CD; Moore SC; Fairfield C; Carter E; Abrams S; Short CE; Thaventhiran T; Bergstrom E; Gardener Z; Ascough S; Chiu C; Docherty AB; Hunt D; Crow YJ; Solomon T; Taylor GP; Turtle L; Harrison EM; Dunning J; Semple MG; Baillie JK; Openshaw PJ;
    Sci Immunol; 2021 Mar; 6(57):. PubMed ID: 33692097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinguishing COVID-19 from seasonal influenza in patients under age 65 years-a retrospective observational cohort study comparing the 2009 influenza A (H1N1) and 2022 SARS-CoV-2 pandemics.
    Zhong W; Wu Y; Yue W; Fang J; Xie B; Xu N; Lin M; Zhu X; Su Z; Chen Y; Li H; Li H
    Front Cell Infect Microbiol; 2023; 13():1179552. PubMed ID: 37533930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of yogurt containing probiotics on respiratory virus infections: Influenza H1N1 and SARS-CoV-2.
    Jeon HY; Kim KS; Kim S
    J Dairy Sci; 2023 Mar; 106(3):1549-1561. PubMed ID: 36631322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of clinical characteristics and outcomes between COVID-19 pneumonia and H1N1 influenza.
    Nasir N; Khanum I; Habib K; Ahmed R; Hussain M; Hasan Z; Irfan M
    Adv Respir Med; 2021; 89(3):254-261. PubMed ID: 34196377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Host Response to Influenza A Virus Interferes with SARS-CoV-2 Replication during Coinfection.
    Oishi K; Horiuchi S; Minkoff JM; tenOever BR
    J Virol; 2022 Aug; 96(15):e0076522. PubMed ID: 35862681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza viruses and SARS-CoV-2 in adult: 'Similarities and differences'.
    Torun Ş; Kesim Ç; Süner A; Botan Yıldırım B; Özen Ö; Akçay Ş
    Tuberk Toraks; 2021 Dec; 69(4):458-468. PubMed ID: 34957739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all?
    Morris G; Bortolasci CC; Puri BK; Marx W; O'Neil A; Athan E; Walder K; Berk M; Olive L; Carvalho AF; Maes M
    Cytokine; 2021 Aug; 144():155593. PubMed ID: 34074585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Cytokine Signatures of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Influenza Infection Highlight Key Differences in Pathobiology.
    Karaba AH; Zhou W; Hsieh LL; Figueroa A; Massaccesi G; Rothman RE; Fenstermacher KZJ; Sauer L; Shaw-Saliba K; Blair PW; Robinson ML; Leung S; Wesson R; Alachkar N; El-Diwany R; Ji H; Cox AL
    Clin Infect Dis; 2022 Jan; 74(2):254-262. PubMed ID: 34013339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial: A Decline in Influenza During the COVID-19 Pandemic and the Emergence of Potential Epidemic and Pandemic Influenza Viruses.
    Parums DV
    Med Sci Monit; 2021 Oct; 27():e934949. PubMed ID: 34602605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case Report: Co-infection with SARS-CoV-2 and influenza H1N1 in a patient with acute respiratory distress syndrome and a pulmonary sarcoidosis.
    Baala L; Benzekri-Lefevre D; Bret L; Guillaume C; Courtellemont L; El Khalil A; Guery T; Iquel S; Perche O; Khadre K; Brungs T; Decker J; Francia T; Bois J; Delamare B; Guinard J; Got L; Briault S; Boulain T; Legac E
    F1000Res; 2020; 9():1482. PubMed ID: 35528205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two pandemics: H1N1 and SARS-CoV-2.
    Kant A; Kostakoğlu U; Saral ÖB; Çomoğlu Ş; Arslan M; Karakoç HN; Erkan G; Ertunç B; Demir HD; Aydin M; Öztürk S; Yilmaz G
    Rev Assoc Med Bras (1992); 2021 Jan; 67(1):115-119. PubMed ID: 34161484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine Signature Associated With Disease Severity in COVID-19.
    Guo J; Wang S; Xia H; Shi D; Chen Y; Zheng S; Chen Y; Gao H; Guo F; Ji Z; Huang C; Luo R; Zhang Y; Zuo J; Chen Y; Xu Y; Xia J; Zhu C; Xu X; Qiu Y; Sheng J; Xu K; Li L
    Front Immunol; 2021; 12():681516. PubMed ID: 34489933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Immunologic Evaluation of Bronchoalveolar Lavage Samples from Human Patients with Moderate and Severe Seasonal Influenza and Severe COVID-19.
    Reynolds D; Vazquez Guillamet C; Day A; Borcherding N; Vazquez Guillamet R; Choreño-Parra JA; House SL; O'Halloran JA; Zúñiga J; Ellebedy AH; Byers DE; Mudd PA
    J Immunol; 2021 Sep; 207(5):1229-1238. PubMed ID: 34348975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 and H1N1-09: A Systematic Review of Two Pandemics with a Focus on the Lung at Autopsy.
    Bertozzi G; Ferrara M; Maiese A; Di Fazio N; Delogu G; Frati P; La Russa R; Fineschi V
    Front Biosci (Landmark Ed); 2022 Jun; 27(6):182. PubMed ID: 35748258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of the COVID-19 pandemic on the global burden of influenza.
    Lampejo T
    J Med Virol; 2022 Jun; 94(6):2357-2359. PubMed ID: 35146774
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 41.